Search

ENANTA PHARMACEUTICALS INC

Deschisă

SectorSănătate

13.99 -0.07

Rezumat

Modificarea prețului

24h

Curent

Minim

13.57

Maxim

14.65

Indicatori cheie

By Trading Economics

Venit

-6.4M

-20M

Vânzări

-2.8M

14M

EPS

-0.67

Marjă de profit

-135.81

Angajați

120

EBITDA

-6.8M

-15M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+41.84% upside

Dividende

By Acuity

Următoarele câștiguri

13 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-27M

374M

Deschiderea anterioară

14.06

Închiderea anterioară

13.99

Sentimentul știrilor

By Acuity

71%

29%

311 / 340 Clasament în Healthcare

ENANTA PHARMACEUTICALS INC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 aug. 2026, 19:06 UTC

News

Enanta Pharmaceuticals is rising despite recent downgrades, remaining above its 20-day moving average. HC Wainwright maintains a "buy" rating with a $20 target.

21 aug. 2026, 19:41 UTC

Enanta Pharmaceuticals is trading higher, supported by gains in biotechnology stocks. The asset remains above its 20-day moving average during Friday's session.

20 aug. 2026, 19:31 UTC

Enanta Pharmaceuticals Inc. shares are lower today amid pressure on biotechnology stocks, continuing a decline since Wednesday's close. No specific news was identified.

18 aug. 2026, 19:16 UTC

Enanta Pharmaceuticals is trading higher today, supported by a rally in the Biotechnology sub-sector. Shares have gained since Monday's close.

17 aug. 2026, 20:06 UTC

Enanta Pharmaceuticals Inc shares are lower today, continuing a decline since Friday amid broader market weakness following a drop in U.S. retail sales.

14 aug. 2026, 20:06 UTC

Enanta Pharmaceuticals is trading lower amid mixed market sentiment following a reported decline in U.S. retail sales for July.

13 aug. 2026, 19:36 UTC

Enanta Pharmaceuticals Inc is trading higher, remaining above its 20-day moving average, despite no specific company news identified for the price movement.

11 aug. 2026, 20:06 UTC

Enanta Pharmaceuticals Inc shares are lower today, reflecting broader market declines. The stock reached a session low earlier but has since recovered slightly.

5 aug. 2026, 19:46 UTC

Enanta Pharmaceuticals Inc shares are lower, reflecting broader market sentiment amid disappointing ADP employment data showing a rise of only 44,000 jobs in July.

4 aug. 2026, 19:46 UTC

Enanta Pharmaceuticals Inc shares are higher, buoyed by a decline in crude oil prices that eases inflation concerns. No specific company news was identified.

3 aug. 2026, 19:23 UTC

Enanta Pharmaceuticals Inc shares are rising amid a broader market rally, supported by gains in major technology stocks and renewed investor confidence.

31 iul. 2026, 20:06 UTC

Enanta Pharmaceuticals Inc's shares are lower today, continuing a downward trend amid rising U.S. Treasury yields and crude oil prices. No specific news was identified.

30 iul. 2026, 19:45 UTC

Enanta Pharmaceuticals Inc. is advancing, supported by broader market gains. Earlier in the session, shares pulled back from a session high.

29 iul. 2026, 18:26 UTC

Enanta Pharmaceuticals Inc is declining in Wednesday's session, marking the seventh consecutive day of lower prices. No specific news has been identified to explain the movement.

28 iul. 2026, 20:06 UTC

Enanta Pharmaceuticals Inc is declining, marking five consecutive sessions lower. The stock peaked earlier but has since pulled back amid broader market pressures.

27 iul. 2026, 18:36 UTC

Enanta Pharmaceuticals Inc is higher today, building on Friday's momentum amid broader market dynamics following a decline in oil prices.

24 iul. 2026, 20:06 UTC

Enanta Pharmaceuticals Inc. shares are lower today, reversing from a recent trend of higher daily closes since Thursday's close.

21 iul. 2026, 19:31 UTC

Enanta Pharmaceuticals is rising during Tuesday's session, reflecting broader market strength and positive sentiment from recent earnings reports by General Motors and Novartis.

20 iul. 2026, 19:46 UTC

Enanta Pharmaceuticals Inc shares are lower today, continuing a decline since Friday's close. The stock has shown significant volatility during the session.

Comparație

Modificare preț

ENANTA PHARMACEUTICALS INC Așteptări

Obiectiv de preț

By TipRanks

41.84% sus

Prognoză pe 12 luni

Medie 20 USD  41.84%

Maxim 20 USD

Minim 20 USD

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruENANTA PHARMACEUTICALS INC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

1

Cumpărare

0

Păstrare

0

Vânzare

Sentiment

By Acuity

311 / 340 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre ENANTA PHARMACEUTICALS INC

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
help-icon Live chat